Susanne Mangold

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Proceedings of the National Academy of Sciences · 2010 · 167 citations

Medicine, Oncology, Pharmacology +17

Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies

Markus Münz, Alexander Murr, Majk Kvesic et al. · Cancer Cell International · 2010 · 122 citations · Full text

Pharmacy, Immunology, Oncology +17

Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA

Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Journal of Immunotherapy · 2009 · 77 citations

Life Sciences, Immunology, Oncology +17

Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release

Maria Amann, Sandrine d’Argouges, Grit Lorenczewski et al. · Journal of Immunotherapy · 2009 · 62 citations

Life Sciences, Immunology, Oncology +17

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 60 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +15